We are interested in how genetic variation influence blood cell formation and blood cancer risk. We work in the interface between genomics, bioinformatics, hematology and immunology. The group is markedly multi-disciplinary, and consists of about 15 members with computational, experimental or clinical expertise.
We are located at Lund University, which hosts one of the leading hematology research environments in Europe. The environment involves some 200 researchers and students at the Biomedical Center (BMC), next to the University Hospital. The environment is equipped with multiple technical platforms to support cutting-edge research in hematology. We are a part of the Division of Hematology and Transfusion Medicine at the Department of Laboratory medicine.
In addition to a strong local environment, a strong, international collaboration network facilitates our activities. This includes FOCUS-MM (a Scandinavian network for research on multiple myeloma genetics) as well as multiple collaborators in academia and industry.
"Identification of sequence variants influencing immunoglobulin levels" Jonsson S et al. Nature Genetics, 19 juni 2017.
”Genome-wide association study identifies multiple susceptibility loci for multiple myeloma.” Mitchell JS et al. Nature Communications. 2016 Jul 1;7:12050.
"Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma" Swaminathan B et al. Nature Communications, 2015 May 26;6:7213
"Robust isolation of malignant plasma cells in multiple myeloma" Frigyesi I et al. Blood 2014.
"Homozygosity for a null allele of SMIM1 defines the Vel-negative blood group phenotype" Storry J et al. Nature Genetics 2013;45(5):537-41.
Full list of publications